Kelly Fleetwood1, Sarah H Wild1, Daniel J Smith2, Stewart W Mercer1, Kirsty Licence3, Cathie L M Sudlow1, Caroline A Jackson4. 1. Usher Institute, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, UK. 2. Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK. 3. Information Services Division, National Services Scotland, NHS Scotland, Edinburgh, UK. 4. Usher Institute, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, UK. caroline.jackson@ed.ac.uk.
Abstract
BACKGROUND: Severe mental illness (SMI), comprising schizophrenia, bipolar disorder and major depression, is associated with higher myocardial infarction (MI) mortality but lower coronary revascularisation rates. Previous studies have largely focused on schizophrenia, with limited information on bipolar disorder and major depression, long-term mortality or the effects of either sociodemographic factors or year of MI. We investigated the associations between SMI and MI prognosis and how these differed by age at MI, sex and year of MI. METHODS: We conducted a national retrospective cohort study, including adults with a hospitalised MI in Scotland between 1991 and 2014. We ascertained previous history of schizophrenia, bipolar disorder and major depression from psychiatric and general hospital admission records. We used logistic regression to obtain odds ratios adjusted for sociodemographic factors for 30-day, 1-year and 5-year mortality, comparing people with each SMI to a comparison group without a prior hospital record for any mental health condition. We used Cox regression to analyse coronary revascularisation within 30 days, risk of further MI and further vascular events (MI or stroke). We investigated associations for interaction with age at MI, sex and year of MI. RESULTS: Among 235,310 people with MI, 923 (0.4%) had schizophrenia, 642 (0.3%) had bipolar disorder and 6239 (2.7%) had major depression. SMI was associated with higher 30-day, 1-year and 5-year mortality and risk of further MI and stroke. Thirty-day mortality was higher for schizophrenia (OR 1.95, 95% CI 1.64-2.30), bipolar disorder (OR 1.53, 95% CI 1.26-1.86) and major depression (OR 1.31, 95% CI 1.23-1.40). Odds ratios for 1-year and 5-year mortality were larger for all three conditions. Revascularisation rates were lower in schizophrenia (HR 0.57, 95% CI 0.48-0.67), bipolar disorder (HR 0.69, 95% CI 0.56-0.85) and major depression (HR 0.78, 95% CI 0.73-0.83). Mortality and revascularisation disparities persisted from 1991 to 2014, with absolute mortality disparities more apparent for MIs that occurred around 70 years of age, the overall mean age of MI. Women with major depression had a greater reduction in revascularisation than men with major depression. CONCLUSIONS: There are sustained SMI disparities in MI intervention and prognosis. There is an urgent need to understand and tackle the reasons for these disparities.
BACKGROUND: Severe mental illness (SMI), comprising schizophrenia, bipolar disorder and major depression, is associated with higher myocardial infarction (MI) mortality but lower coronary revascularisation rates. Previous studies have largely focused on schizophrenia, with limited information on bipolar disorder and major depression, long-term mortality or the effects of either sociodemographic factors or year of MI. We investigated the associations between SMI and MI prognosis and how these differed by age at MI, sex and year of MI. METHODS: We conducted a national retrospective cohort study, including adults with a hospitalised MI in Scotland between 1991 and 2014. We ascertained previous history of schizophrenia, bipolar disorder and major depression from psychiatric and general hospital admission records. We used logistic regression to obtain odds ratios adjusted for sociodemographic factors for 30-day, 1-year and 5-year mortality, comparing people with each SMI to a comparison group without a prior hospital record for any mental health condition. We used Cox regression to analyse coronary revascularisation within 30 days, risk of further MI and further vascular events (MI or stroke). We investigated associations for interaction with age at MI, sex and year of MI. RESULTS: Among 235,310 people with MI, 923 (0.4%) had schizophrenia, 642 (0.3%) had bipolar disorder and 6239 (2.7%) had major depression. SMI was associated with higher 30-day, 1-year and 5-year mortality and risk of further MI and stroke. Thirty-day mortality was higher for schizophrenia (OR 1.95, 95% CI 1.64-2.30), bipolar disorder (OR 1.53, 95% CI 1.26-1.86) and major depression (OR 1.31, 95% CI 1.23-1.40). Odds ratios for 1-year and 5-year mortality were larger for all three conditions. Revascularisation rates were lower in schizophrenia (HR 0.57, 95% CI 0.48-0.67), bipolar disorder (HR 0.69, 95% CI 0.56-0.85) and major depression (HR 0.78, 95% CI 0.73-0.83). Mortality and revascularisation disparities persisted from 1991 to 2014, with absolute mortality disparities more apparent for MIs that occurred around 70 years of age, the overall mean age of MI. Women with major depression had a greater reduction in revascularisation than men with major depression. CONCLUSIONS: There are sustained SMI disparities in MI intervention and prognosis. There is an urgent need to understand and tackle the reasons for these disparities.
Authors: Lars Jakobsen; Christian J Terkelsen; Evald H Christiansen; Michael Maeng; Lisette O Jensen; Karsten Veien; Bent Raungaard; Svend E Jensen; Frank Mehnert; Søren P Johnsen Journal: Am J Cardiol Date: 2017-05-30 Impact factor: 2.778
Authors: Pirathiv Kugathasan; Thomas Munk Laursen; Simon Grøntved; Svend Eggert Jensen; Jørgen Aagaard; René Ernst Nielsen Journal: Schizophr Res Date: 2018-03-16 Impact factor: 4.939
Authors: Joshua Schulman-Marcus; Parag Goyal; Rajesh V Swaminathan; Dmitriy N Feldman; Shing-Chiu Wong; Harsimran S Singh; Robert M Minutello; Geoffrey Bergman; Luke K Kim Journal: Am J Cardiol Date: 2016-02-17 Impact factor: 2.778
Authors: Joshua Schulman-Marcus; Tara Shah; Rajesh V Swaminathan; Dmitriy N Feldman; Shing-Chiu Wong; Harsimran S Singh; Robert M Minutello; Geoffrey Bergman; Luke K Kim Journal: Am J Cardiol Date: 2016-06-28 Impact factor: 2.778
Authors: Oleguer Plana-Ripoll; Carsten Bøcker Pedersen; Esben Agerbo; Yan Holtz; Annette Erlangsen; Vladimir Canudas-Romo; Per Kragh Andersen; Fiona J Charlson; Maria K Christensen; Holly E Erskine; Alize J Ferrari; Kim Moesgaard Iburg; Natalie Momen; Preben Bo Mortensen; Merete Nordentoft; Damian F Santomauro; James G Scott; Harvey A Whiteford; Nanna Weye; John J McGrath; Thomas M Laursen Journal: Lancet Date: 2019-10-24 Impact factor: 79.321
Authors: Shu-I Wu; Su-Chiu Chen; Shen-Ing Liu; Fang-Ju Sun; Jimmy J M Juang; Hsin-Chien Lee; Kai-Liang Kao; Michael E Dewey; Martin Prince; Robert Stewart Journal: PLoS One Date: 2015-08-13 Impact factor: 3.240
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: PLoS Med Date: 2007-10-16 Impact factor: 11.069
Authors: Joe Kwun Nam Chan; Ryan Sai Ting Chu; Chun Hung; Jenny Wai Yiu Law; Corine Sau Man Wong; Wing Chung Chang Journal: Schizophr Bull Date: 2022-09-01 Impact factor: 7.348
Authors: Naomi Launders; Kate Dotsikas; Louise Marston; Gabriele Price; David P J Osborn; Joseph F Hayes Journal: PLoS One Date: 2022-08-18 Impact factor: 3.752
Authors: Konsta Teppo; Jussi Jaakkola; Fausto Biancari; Olli Halminen; Jukka Putaala; Pirjo Mustonen; Jari Haukka; Miika Linna; Janne Kinnunen; Alex Luojus; Saga Itäinen-Strömberg; Tero Penttilä; Mikko Niemi; Juha Hartikainen; Ke Juhani Airaksinen; Mika Lehto Journal: BMJ Open Date: 2022-08-30 Impact factor: 3.006
Authors: Konsta Teppo; Jussi Jaakkola; Fausto Biancari; Olli Halminen; Jukka Putaala; Pirjo Mustonen; Jari Haukka; Miika Linna; Janne Kinnunen; Paula Tiili; Elis Kouki; Tero Penttilä; Juha Hartikainen; Aapo L Aro; K E Juhani Airaksinen; Mika Lehto Journal: Eur J Clin Invest Date: 2022-05-07 Impact factor: 5.722
Authors: Sara Guillen-Aguinaga; Antonio Brugos-Larumbe; Laura Guillen-Aguinaga; Felipe Ortuño; Francisco Guillen-Grima; Luis Forga; Ines Aguinaga-Ontoso Journal: J Cardiovasc Dev Dis Date: 2022-01-13